Q&A With Dina Kao From University of Alberta: Working to 'Advance the Science' of Fecal Microbiota Transplant

Patients with C-Diff are being treated with fecal microbiota transplantation but there is still more research being done in the field to learn more about the potential benefits in the field.

Patients with C-Diff are being treated with fecal microbiota transplantation but there is still more research being done in the field to learn more about the potential benefits in the field.

Dina Kao, MD, from the University of Alberta was part of a team that presented the results of a study on the topic during Digestive Disease Week in Washintgon, DC. Kao said the procedure has become a common treatment option so work can now be done to see how it can be done for other conditions and helping as many patients as possible. "There's just so many unanswered questions when it comes to fecal transplant," she said.